Lineage Cell Therapeutics, Inc.

Ownership Transactions Reported by 15 Insiders

Symbol
LCTX on NYSE
Location
2173 Salk Avenue, Suite 200, Carlsbad, CA

Insiders trading volume in the past year

Lineage Cell Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Broadwood Partners, L.P. Director, 10%+ Owner $86.7M +$7M +8.79% Feb 6, 2024
Brian M. Culley President and CEO, Director $273K +$34.5K +14.4% Nov 21, 2024
Michael H. Mulroy Director $169K +$22.6K +15.5% Nov 22, 2024
Don M. Bailey Director $165K +$100K +153% Jul 1, 2024
George A. Samuel III General Counsel $21.1K +$9K +74.6% Nov 26, 2024
Jill A. Howe Chief Financial Officer $15K +$18.2K Nov 26, 2024
Anula Jayasuriya Director $10.9K +$10.9K Jul 1, 2024
Dipti Amin Director Jul 1, 2024
Deborah J. Andrews Director Jul 1, 2024
Kevin Leon Cook Chief Financial Officer Mar 10, 2022
Gary S. Hogge SVP,Clinical & Medical Affairs Mar 9, 2023
Alexandra Hernandez Sr Director Finance/Controller Jul 7, 2022
Angus C. Russell Director Jul 1, 2024
Neal C. Bradsher Director, 10%+ Owner Jul 1, 2024
Alfred D. Kingsley Chairman, Director Jul 1, 2023

Recent Insider Transactions by Companies or Individuals for Lineage Cell Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.